Building Consistent Income in a Dividend Stock Portfolio with Abbott Laboratories (ABT)

Abbott Laboratories (NYSE:ABT) is included among the Best Retirement Stocks for a Dividend Stock Portfolio.

Abbott Laboratories (NYSE:ABT) operates a broad business spanning four main areas: medical devices, established pharmaceuticals, diagnostics, and nutrition. With a strong global presence, its diversified structure helps balance performance when one segment experiences weakness.

Abbott Laboratories (NYSE:ABT) also sees several major long-term growth opportunities. Among the most promising is its FreeStyle Libre product line, a continuous glucose monitoring system that allows people with diabetes to track blood sugar levels. This has been a leading growth driver for Abbott and still has considerable room to expand. In addition, the company continues to advance through ongoing innovation and by securing approvals for new medical devices.

Abbott Laboratories (NYSE:ABT) is a solid dividend company. On September 19, the company declared a quarterly dividend of $0.59 per share, which was in line with its previous dividend. Overall, it has been rewarding shareholders with growing dividends for 53 consecutive years, which makes ABT one of the best stocks for a dividend stock portfolio. As of September 21, the stock has a dividend yield of 1.73%.

While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best S&P 500 Dividend Stocks to Invest in and 10 Safest High Dividend Stocks to Buy Now

Disclosure: None.